Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a … T Pillinger, RA McCutcheon, L Vano, Y Mizuno, A Arumuham, G Hindley, ... The Lancet Psychiatry 7 (1), 64-77, 2020 | 825 | 2020 |
Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis AH Ashok, Y Mizuno, ND Volkow, OD Howes JAMA psychiatry 74 (5), 511-519, 2017 | 334 | 2017 |
Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis Y Mizuno, T Suzuki, A Nakagawa, K Yoshida, M Mimura, ... Schizophrenia Bulletin 40 (6), 1385-1403, 2014 | 235 | 2014 |
Resilience, internalized stigma, self-esteem, and hopelessness among people with schizophrenia: Cultural comparison in Austria and Japan A Hofer, Y Mizuno, B Frajo-Apor, G Kemmler, T Suzuki, S Pardeller, ... Schizophrenia research 171 (1-3), 86-91, 2016 | 116 | 2016 |
Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions' approaches to an evolving healthcare landscape S Kinoshita, K Cortright, A Crawford, Y Mizuno, K Yoshida, D Hilty, ... Psychological medicine 52 (13), 2606-2613, 2022 | 114 | 2022 |
Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis Y Mizuno, RA McCutcheon, SP Brugger, OD Howes Neuropsychopharmacology 45 (4), 622-631, 2020 | 97 | 2020 |
Clinical and biological correlates of resilience in patients with schizophrenia and bipolar disorder: A cross-sectional study Y Mizuno, A Hofer, T Suzuki, B Frajo-Apor, F Wartelsteiner, G Kemmler, ... Schizophrenia Research 175 (1-3), 148-153, 2016 | 90 | 2016 |
Resilience and spirituality in patients with depression and their family members: A cross-sectional study C Ozawa, T Suzuki, Y Mizuno, R Tarumi, K Yoshida, K Fujii, J Hirano, ... Comprehensive psychiatry 77, 53-59, 2017 | 87 | 2017 |
The efficacy and heterogeneity of antipsychotic response in schizophrenia: a meta-analysis RA McCutcheon, T Pillinger, Y Mizuno, A Montgomery, H Pandian, ... Molecular psychiatry 26 (4), 1310-1320, 2021 | 84 | 2021 |
Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilience A Hofer, Y Mizuno, F Wartelsteiner, WW Fleischhacker, B Frajo-Apor, ... European Psychiatry 46, 42-47, 2017 | 79 | 2017 |
Quality of life in stabilized outpatients with bipolar I disorder: Associations with resilience, internalized stigma, and residual symptoms F Post, S Pardeller, B Frajo-Apor, G Kemmler, C Sondermann, ... Journal of Affective Disorders 238, 399-404, 2018 | 63 | 2018 |
Resilience research in schizophrenia: A review of recent developments Y Mizuno, F Wartelsteiner, B Frajo-Apor Current opinion in psychiatry 29 (3), 218-223, 2016 | 60 | 2016 |
Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies AH Ashok, Y Mizuno, OD Howes Psychopharmacology 236, 1119-1129, 2019 | 44 | 2019 |
Effects of chair yoga therapy on physical fitness in patients with psychiatric disorders: A 12-week single-blind randomized controlled trial S Ikai, H Uchida, Y Mizuno, H Tani, M Nagaoka, K Tsunoda, M Mimura, ... Journal of Psychiatric Research 94, 194-201, 2017 | 40 | 2017 |
Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data K Yoshida, RR Bies, T Suzuki, G Remington, BG Pollock, Y Mizuno, ... Schizophrenia research 153 (1-3), 184-188, 2014 | 38 | 2014 |
Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: a cross-sectional study Y Mizuno, RR Bies, G Remington, DC Mamo, T Suzuki, BG Pollock, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 37 (1), 182-187, 2012 | 32 | 2012 |
Melancholic and reactive depression: a reappraisal of old categories J Mizushima, H Sakurai, Y Mizuno, M Shinfuku, H Tani, K Yoshida, ... BMC psychiatry 13, 1-6, 2013 | 30 | 2013 |
The magnitude and heterogeneity of antidepressant response in depression: a meta-analysis of over 45,000 patients X Guo, RA McCutcheon, T Pillinger, Y Mizuno, S Natesan, K Brown, ... Journal of Affective Disorders 276, 991-1000, 2020 | 20 | 2020 |
Resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan K Yoshida, T Suzuki, Y Imasaka, K Kubo, Y Mizuno, J Saruta, K Tsukinoki, ... Schizophrenia Research 171 (1-3), 92-96, 2016 | 20 | 2016 |
Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies Y Mizuno, AH Ashok, BB Bhat, S Jauhar, OD Howes Journal of Psychopharmacology 37 (11), 1058-1069, 2023 | 17 | 2023 |